Rh hemolytic disease of the newborn: its cause and prevention.
D000017:ABO Blood-Group System; D000818:Animals; D001787:Blood Group Incompatibility; D002986:Clinical Trials as Topic; D003888:Desensitization, Immunologic; D004306:Dose-Response Relationship, Immunologic; D004899:Erythroblastosis, Fetal / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007114:Immunization; D007136:Immunoglobulins / Q000627:therapeutic use; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D012204:Rh-Hr Blood-Group System / Q000627:therapeutic use; D018029:Rho(D) Immune Globulin; D012306:Risk
D000017:ABO Blood-Group System; D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin